Article
Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex.
eLife - 10 Dec 2015
Carelli Jordan D, Sethofer Steven G, Smith Geoffrey A, Miller Howard R, Simard Jillian L, Merrick William C, Jain Rishi K, Ross Nathan T, Taunton Jack
Abstract excerpt
Cyclic peptide natural products have evolved to exploit diverse protein targets, many of which control essential cellular processes. Inspired by a series of cyclic peptides with partially elucidated structures, we designed synthetic variants of ternatin, a cytotoxic and anti-adipogenic natural product whose molecular mode of action was unknown. The new ternatin variants are cytotoxic toward cancer cells, with up...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
